GLYSET Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Glyset, and what generic alternatives are available?

Glyset is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in GLYSET is miglitol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the miglitol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Glyset

A generic version of GLYSET was approved as miglitol by WESTMINSTER PHARMS on February 24^th, 2015.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for GLYSET?
What are the global sales for GLYSET?
What is Average Wholesale Price for GLYSET?

Summary for GLYSET

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	88
Patent Applications:	4,554
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for GLYSET
What excipients (inactive ingredients) are in GLYSET?	GLYSET excipients list
DailyMed Link:	GLYSET at DailyMed

Drug patent expirations by year for GLYSET

US Patents and Regulatory Information for GLYSET

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-001	Dec 18, 1996	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-002	Dec 18, 1996	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-003	Dec 18, 1996	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for GLYSET

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-001	Dec 18, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-003	Dec 18, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	GLYSET	miglitol	TABLET;ORAL	020682-002	Dec 18, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for GLYSET

See the table below for patents covering GLYSET around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	S6231703		⤷ Sign Up
Austria	376420		⤷ Sign Up
Spain	472838		⤷ Sign Up
European Patent Office	1420659		⤷ Sign Up
U.S.S.R.	1014470	PROCESS FOR PREPARING DERIVATIVES OF 3,4,5-THIOXYPIPIDINE	⤷ Sign Up
Italy	1111197	DERIVATI DELLA 3,4,5-TRIIDROSSIPIPE RIDINA,PROCESSI PER LA LORO PRODUZIONE E LORO IMPIEGO	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for GLYSET

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0266730	98C0014	Belgium	⤷ Sign Up	PRODUCT NAME: MIGLITOL; NAT. REGISTRATION NO/DATE: NL 22 138 19970204; FIRST REGISTRATION: NL - 19 343 UR 19960723
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for GLYSET

Make Better Decisions: Try a trial or see plans & pricing